Real‑world patterns of Alzheimer’s disease biomarker testing: Insights from a large‑scale clinical dataset
Sponsored by: Labcorp
Using data from 234,450 patients, this analysis reveals how Alzheimer’s biomarkers are ordered, sequenced, and repeated in real‑world care, highlighting variability beyond clinical trials and the value of large‑scale RWD. Learn how these insights can inform research and diagnostics.
Biopharma teams often make critical decisions without timely expert input. Simulated Advisory Boards deliver expert-informed insights in days, helping teams test assumptions, explore stakeholder perspectives, and identify risks early. Make smarter decisions, faster. Download the white paper.
Curium’s Mike Patterson on improving access, safety and trust to scale theranostics and enhance patient care.
Industry Event
Oncology solutions from Labcorp
Sponsored by: Labcorp
Our precision oncology solutions empower biomarker-driven clinical trials and CDx development even when tissue is unavailable—for clear insights at every step of development. Meet us May 30 – June 1.
